ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,664Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 199

$976K Total Retail Price of All Prescriptions

Rank: 11 out of 199

725 Patients Receiving at Least One Drug in Part D
94% Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nebraska
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

5% of this provider’s 725 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 725 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 1,171 1,109 193 1 1
SIMVASTATIN 860 819 159 2 2
AMLODIPINE BESYLATE 820 788 134 3 3
OMEPRAZOLE 719 699 121 4 4
FUROSEMIDE 664 659* 85 5 5
POTASSIUM CHLORIDE 590 567 106 6 10
WARFARIN SODIUM 575 575 91 7 7
ATORVASTATIN CALCIUM 537 537 95 8 8
LOSARTAN POTASSIUM 505 480 80 9 15
METOPROLOL SUCCINATE 486 481* 69 10 11
LISINOPRIL 426 409 80 11 6
PRAVASTATIN SODIUM 407 378 66 12 18
METFORMIN HCL 386 356 69 13 13
ALPRAZOLAM 342 323 62 B 14 24
CARVEDILOL 296 291* 57 15 21
TORSEMIDE 291 286* 56 16 89
ATENOLOL 271 247 47 17 19
QUINAPRIL HCL 260 242 43 18 140
HYDROCODONE-ACETAMINOPHEN 257 246 65 S3 19 9
CITALOPRAM HBR 240 240 37 20 20
ALLOPURINOL 233 233 37 21 22
METOPROLOL TARTRATE 229 207 32 22 12
PREDNISONE 228 223* 62 23 33
GABAPENTIN 203 198* 44 24 14
GLIPIZIDE ER 196 169 31 25 110
FELODIPINE ER 192 192 30 26 170
CRESTOR 185 157 31 27 31
SERTRALINE HCL 176 171* 33 28 23
TRAMADOL HCL 175 151 48 29 16
TAMSULOSIN HCL 170 170 34 30 26
ZETIA 161 161 23 31 70
ALENDRONATE SODIUM 160 155* 26 32 29
PANTOPRAZOLE SODIUM 153 148* 26 33 25
CLOPIDOGREL 151 151 29 34 27
RANITIDINE HCL 151 122 26 34 57
ZOLPIDEM TARTRATE 149 144* 32 36 28
RAMIPRIL 148 124 24 37 79
ISOSORBIDE MONONITRATE ER 141 136* 20 38 66
NAMENDA 132 132 14 39 34
LEVOFLOXACIN 131 126* 104 40 80
MONTELUKAST SODIUM 130 119 38 41 58
DONEPEZIL HCL 128 128 18 42 30
CARBIDOPA-LEVODOPA 122 122 15 43 88
TERAZOSIN HCL 119 119 20 44 117
CLONIDINE HCL 118 113* 21 45 52
GLIMEPIRIDE 118 113* 20 45 38
GLIPIZIDE 113 113 17 47 61
GLIPIZIDE XL 113 113 16 47 149
BYSTOLIC 112 112 19 49 54
MELOXICAM 111 106* 22 50 32
POLYETHYLENE GLYCOL 3350 108 93 28 51 45
NADOLOL 108 103* 19 51 207
FLUTICASONE PROPIONATE 105 92 29 53 35
NEXIUM 103 103 15 54 46
PAROXETINE HCL 102 90 11 55 73
LEVEMIR FLEXPEN 102 97* 20 55 108
QUETIAPINE FUMARATE 99 99 16 A 57 53
DILTIAZEM 24HR CD 98 98 12 58 172
OXYBUTYNIN CHLORIDE 96 70 14 59 97
RISPERIDONE 95 59 11 A 60 90
ACEBUTOLOL HCL 94 94 18 61 233
LORAZEPAM 91 91 17 B 62 40
SYNTHROID 91 86* 18 62 41
PIOGLITAZONE HCL 89 71 13 R 64 86
IRBESARTAN 89 84* 21 64 161
VERAPAMIL ER 88 75 17 66 142
MIRTAZAPINE 88 88 15 66 47
ESCITALOPRAM OXALATE 88 88 22 66 36
CELEBREX 88 88 17 66 63
KLOR-CON 10 85 80* 15 70 134
DILTIAZEM ER 81 81 11 71 141
KLOR-CON M10 80 80 12 72 99
PROPRANOLOL HCL 78 78 11 73 94
LABETALOL HCL 78 78 14 73 177
DIOVAN 74 69* 18 75 42
LOVASTATIN 73 68* 11 76 71
HYDROCHLOROTHIAZIDE 71 66* 19 77 17
SPIRIVA 69 69 11 78 69
ADVAIR DISKUS 65 65 11 79 51
CIPROFLOXACIN HCL 63 58* 49 80 56
FENOFIBRATE* 62 46 11 81 59
TRAZODONE HCL 60 60 13 82 50
TEKTURNA 60 <11 <11 82 260
AMIODARONE HCL 59 <11 <11 84 111
LANSOPRAZOLE 59 59 11 84 175
FLURBIPROFEN 59 59 11 84 264
OXYCODONE-ACETAMINOPHEN 58 53* 12 S2 87 87
TRIAMTERENE-HCTZ 58 58 14 87 37
VENLAFAXINE HCL ER 58 <11 <11 87 76
IBANDRONATE SODIUM 56 <11 <11 90 226
LOSARTAN-HYDROCHLOROTHIAZIDE 55 <11 <11 91 49
OXYBUTYNIN CHLORIDE ER 55 <11 <11 91 102
DIGOX 53 <11 <11 93 109
PRAMIPEXOLE DIHYDROCHLORIDE 53 <11 <11 93 122
DILTIAZEM 24HR ER 53 <11 <11 93 147
NIASPAN 52 52 11 96 206
FAMOTIDINE* 52 <11 <11 96 64
AMLODIPINE BESYLATE-BENAZEPRIL 52 <11 <11 96 98
PENTOXIFYLLINE 52 <11 <11 96 281
ESTRADIOL 51 51 15 R 100 146
DIAZEPAM 51 51 17 B 100 136
AMITRIPTYLINE HCL 50 45* 14 R 102 75
BENAZEPRIL HCL 50 45* 11 102 48
DICLOFENAC SODIUM 50 45* 13 102 199
VALSARTAN-HYDROCHLOROTHIAZIDE 50 <11 <11 102 83
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 27, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.